Heparanase Released From Mesenchymal Stem Cells Activates Integrin beta1/HIF-2alpha/Flk-1 Signaling and Promotes Endothelial Cell Migration and Angiogenesis

Heparanase plays important roles in tumor angiogenesis. Our previous study demonstrated that hypoxic preconditioning (HPC) enhanced the angiogenic and therapeutic effects of mesenchymal stem cells (MSCs), effects that were paralleled by enhanced heparanase expression. This study was designed to elucidate the role of heparanase in the improved therapeutic properties of HPC‐MSCs and to explore underlying mechanisms using an ischemic rat hind limb model. MSCs transfected with heparanase (MSChpa) or empty vector (MSCnull) were delivered by intramuscular injections to ischemic hind limbs. Hind limbs that received MSChpa recovered blood flow more rapidly at 7 days and acquired higher capillary density at 14 days compared with MSCnull. Conditioned medium from MSChpa increased endothelial cell migration and promoted greater tube formation relative to that from the MSCnull groups. Vascular endothelial growth factor receptor 2 (VEGFR2, Flk‐1) and its downstream signaling pathway (p38MAPK/HSP27) were significantly increased in human umbilical vein endothelial cells (HUVECs) after treatment with MSChpa conditioned medium. Each of these responses was decreased by cocultured with MSChpa‐KD conditioned medium. MSChpa conditioned medium activated hypoxia‐inducible factor‐2α (HIF‐2α) and increased in parallel the transcript level of Flk‐1 as determined by chromatin immunoprecipitation‐PCR and luciferase assays. Analyses of integrin expression revealed an important role for integrin β1 in the regulation of HIF‐2α. All angiogenic effects of MSChpa conditioned medium were abolished by knockdown of integrin β1, HIF‐2α, and Flk‐1 in HUVECs with selective shRNAs. These findings identify heparanse as a key regulator of angiogenesis by MSCs. We propose a novel pathway wherein heparanse sequentially activates integrin β1, HIF‐2α, Flk‐1, and p38MAPK/HSP27 with corresponding enhancement of angiogenesis. Stem Cells 2015;33:1850–1862

[1]  S. Poitevin,et al.  Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity. , 2014, Cardiovascular research.

[2]  C. Page,et al.  Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium. , 2014, American journal of physiology. Cell physiology.

[3]  F. Zunino,et al.  The potential of heparanase as a therapeutic target in cancer. , 2014, Biochemical pharmacology.

[4]  Hae-Chul Park,et al.  CXXC5 is a transcriptional activator of Flk‐1 and mediates bone morphogenic protein‐induced endothelial cell differentiation and vessel formation , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Yu Zhou,et al.  SIRT1 ameliorates age-related senescence of mesenchymal stem cells via modulating telomere shelterin , 2014, Front. Aging Neurosci..

[6]  J. Cha,et al.  The Role of Prolyl Hydroxylase Domain Protein (PHD) during Rosiglitazone-induced Adipocyte Differentiation* , 2013, The Journal of Biological Chemistry.

[7]  C. Teng,et al.  TUMORIGENESIS AND NEOPLASTIC PROGRESSION Activated PAR-2 Regulates Pancreatic Cancer Progression through ILK / HIF-a e Induced TGF-a Expression and MEK / VEGF-A e Mediated Angiogenesis , 2013 .

[8]  C. Jiang,et al.  Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase , 2013, International journal of molecular medicine.

[9]  T. O’Brien,et al.  Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia , 2012, Stem Cell Research & Therapy.

[10]  R. Shao,et al.  Glioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation* , 2012, The Journal of Biological Chemistry.

[11]  A. Erdreich-Epstein,et al.  Heparanase-Induced GEF-H1 Signaling Regulates the Cytoskeletal Dynamics of Brain Metastatic Breast Cancer Cells , 2012, Molecular Cancer Research.

[12]  A. Proweller,et al.  Inhibition of ARNT severely compromises endothelial cell viability and function in response to moderate hypoxia , 2012, Angiogenesis.

[13]  A. Purushothaman,et al.  Heparanase-mediated Loss of Nuclear Syndecan-1 Enhances Histone Acetyltransferase (HAT) Activity to Promote Expression of Genes That Drive an Aggressive Tumor Phenotype* , 2011, The Journal of Biological Chemistry.

[14]  Guodong Yang,et al.  Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury , 2011, European heart journal.

[15]  W. Schaper,et al.  Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis , 2010, Molecular and Cellular Biochemistry.

[16]  H. Mellor,et al.  VEGF receptor trafficking in angiogenesis. , 2009, Biochemical Society transactions.

[17]  Thomas Korff,et al.  Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia , 2009, Nature Protocols.

[18]  R. Sanderson,et al.  Heparanase: busy at the cell surface. , 2009, Trends in biochemical sciences.

[19]  A. Harris,et al.  Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. , 2009, Blood.

[20]  S. Keely,et al.  Selective induction of integrin βi by hypoxia‐inducible factor: implications for wound healing , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Jun O. Liu,et al.  Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells , 2009, Proceedings of the National Academy of Sciences.

[22]  M. Roy,et al.  Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis , 2009, Journal of cellular biochemistry.

[23]  S. Polak‐Charcon,et al.  Constitutive Expression of HIF‐1α and HIF‐2α in Bone Marrow Stromal Cells Differentially Promotes Their Proangiogenic Properties , 2008, Stem cells.

[24]  I. Evans,et al.  Vascular endothelial growth factor induces heat shock protein (HSP) 27 serine 82 phosphorylation and endothelial tubulogenesis via protein kinase D and independent of p38 kinase. , 2008, Cellular signalling.

[25]  U. Förstermann,et al.  Protein kinase C α promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor , 2008 .

[26]  Ling Wei,et al.  Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. , 2008, The Journal of thoracic and cardiovascular surgery.

[27]  Ramesh Vidavalur,et al.  Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1 , 2008, Journal of cellular and molecular medicine.

[28]  Giselle Chamberlain,et al.  Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing , 2007, Stem cells.

[29]  W. Schaper,et al.  Insights into pathways of arteriogenesis. , 2007, Current pharmaceutical biotechnology.

[30]  C. Heeschen,et al.  Low-Energy Shock Wave for Enhancing Recruitment of Endothelial Progenitor Cells: A New Modality to Increase Efficacy of Cell Therapy in Chronic Hind Limb Ischemia , 2006, Circulation.

[31]  M. Ashraf,et al.  Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine Signaling , 2006, Circulation research.

[32]  I. Vlodavsky,et al.  Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. , 2006, Cancer research.

[33]  F. Gage,et al.  Cell fusion-independent differentiation of neural stem cells to the endothelial lineage , 2004, Nature.

[34]  M. Flugelman,et al.  Heparanase Induces Endothelial Cell Migration via Protein Kinase B/Akt Activation* , 2004, Journal of Biological Chemistry.

[35]  I. Vlodavsky,et al.  Heparanase affects adhesive and tumorigenic potential of human glioma cells. , 2003, Cancer research.

[36]  Till Acker,et al.  Cooperative Interaction of Hypoxia-inducible Factor-2α (HIF-2α) and Ets-1 in the Transcriptional Activation of Vascular Endothelial Growth Factor Receptor-2 (Flk-1)* , 2003, The Journal of Biological Chemistry.

[37]  Jun Yamashita,et al.  Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.

[38]  J. Hedges,et al.  A Role for p38MAPK/HSP27 Pathway in Smooth Muscle Cell Migration* , 1999, The Journal of Biological Chemistry.

[39]  P. Cahill,et al.  Effect of Pulse Pressure on Vascular Smooth Muscle Cell Migration: The Role of Urokinase and Matrix Metalloproteinase , 1999, Thrombosis and Haemostasis.

[40]  S. Shimba,et al.  Transcriptional regulation of the hypoxia inducible factor-2α (HIF-2α) gene during adipose differentiation in 3T3-L1 cells , 2006 .

[41]  S. Shimba,et al.  Transcriptional Regulation of the Hypoxia Inducible Factor-2 a ( HIF-2 a ) Gene during Adipose Differentiation in 3 T 3L 1 Cells , 2005 .